Related content

Familial aggregation of circulating c-reactive protein in polycystic ovary syndrome

By Sasidevi Arunachalam   Vellanki Priyathama   Kunselman Allen R.   Raja-Khan Nazia   Dunaif Andrea   Legro Richard S.  

Human Reproduction, Vol. 28, Iss. 3, 2013-03 ,pp. : 770-776

Oxford University Press

Access to resources Recommend Favorite

Should patients with polycystic ovary syndrome be treated with metformin?

By Stadtmauer Laurel A.   Wong Benjamin C.   Oehninger Sergio  

Human Reproduction, Vol. 17, Iss. 12, 2002-12 ,pp. : 3016-3026

Oxford University Press

Access to resources Recommend Favorite

Homocysteine levels in women with polycystic ovary syndrome treated with metformin versus rosiglitazone: a randomized study

By Kilicdag Esra Bulgan   Bagis Tayfun   Zeyneloglu Hulusi B.   Tarim Ebru   Aslan Erdogan   Haydardedeoglu Bulent   Erkanli Serkan  

Human Reproduction, Vol. 20, Iss. 4, 2005-04 ,pp. : 894-899

Oxford University Press

Access to resources Recommend Favorite

Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women: results of a randomized study

By Vanky E.  

Human Reproduction, Vol. 19, Iss. 8, 2004-08 ,pp. : 1734-1740

Oxford University Press

Access to resources Recommend Favorite

The impact of oral contraceptives and metformin on anti-Müüllerian hormone serum levels in women with polycystic ovary syndrome and biochemical hyperandrogenemia

By Panidis Dimitrios   Georgopoulos Neoklis A.   Piouka Athanasia   Katsikis Ilias   Saltamavros Alexandros D.   Decavalas George   Diamanti-Kandarakis Evanthia  

Gynecological Endocrinology, Vol. 27, Iss. 8, 2011-08 ,pp. : 587-592

Informa Healthcare

Access to resources Recommend Favorite